Search Results

Tighter controls for ephedrine and pseudoephedrine contained in nasal decongestants will become law from 1 April 2008

Source: Reactions, Volume 1, Number 1184, 2008-01-12 , pp. 4-4(1)

Publisher: Adis International

Colchicine prescribing and safety monitoring on track in NZ

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 542, 2007-12-01 , pp. 7-7(1)

Publisher: Adis International

Colchicine prescribing and safety monitoring on track in NZ

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 3-3(1)

Publisher: Adis International

Atypical antipsychotic utilisation among NZ kids

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 533, 2007-07-28 , pp. 6-6(1)

Publisher: Adis International

Postmarketing study supports rosuvastatin safety

Source: Reactions, Volume 1, Number 1140, 2007-02-24 , pp. 4-4(1)

Publisher: Adis International

US dermatologists seek to delay start of iPLEDGE programme

Source: Reactions, Volume 1, Number 1089, 2006-02-18 , pp. 4-4(1)

Publisher: Adis International

PEM study shows Yasmin may be associated with thrombosis

Source: Reactions, Volume 1, Number 1063, 2005-08-06 , pp. 3-3(1)

Publisher: Adis International

PEM study shows Yasmin may be associated with thrombosis

Source: Inpharma, Volume 1, Number 1499, 2005-08-06 , pp. 20-20(1)

Publisher: Adis International

News from the 4th annual meeting of the ISOP

Source: Reactions, Volume 1, Number 1025, 2004-10-30 , pp. 2-3(2)

Publisher: Adis International

PEM shows celecoxib "fairly well tolerated" in general practice

Source: Inpharma, Volume 1, Number 1460, 2004-10-23 , pp. 19-19(1)

Publisher: Adis International

Evaluation of the safety profile of bupropion in smoking cessation

Source: Reactions, Volume 1, Number 986, 2004 , pp. 4-4(1)

Publisher: Adis International

Finasteride/tamsulosin: no serious, unexpected adverse events

Source: Inpharma, Volume 1, Number 1301, 2001 , pp. 21-21(1)

Publisher: Adis International

Finasteride/tamsulosin: no serious, unexpected adverse events

Source: Reactions, Volume 1, Number 865, 2001 , pp. 3-3(1)

Publisher: Adis International

Cardiovascular events with sildenafil: incidence findings disputed

Source: Reactions, Volume 1, Number 860, 2001 , pp. 3-3(1)

Publisher: Adis International

No evidence for increased risk of MI or IHD in sildenafil users

Source: Inpharma, Volume 1, Number 1280, 2001 , pp. 20-20(1)

Publisher: Adis International

No evidence for increased risk of MI or IHD in sildenafil users

Source: Reactions, Volume 1, Number 844, 2001 , pp. 4-4(1)

Publisher: Adis International

PEM study shows favourable safety profile for nicorandil

Source: Reactions, Volume 1, Number 759, 1999 , pp. 3-3(1)

Publisher: Adis International

In utero fluconazole exposure not linked to dysmorphogenesis

Source: Reactions, Volume 1, Number 767, 1999 , pp. 4-4(1)

Publisher: Adis International

Challenges for pharmacovigilance in the new millennium

Source: Reactions, Volume 1, Number 775, 1999 , pp. 3-4(2)

Publisher: Adis International

Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors

Authors: Edwards J.G.; Anderson I.

Source: Drugs, Volume 57, Number 4, April 1999 , pp. 507-533(27)

Publisher: Adis International